Baseline Laboratory Panel for a 65-Year-Old Female with Type 2 Diabetes
Order HbA1c, fasting lipid panel (total cholesterol, LDL, HDL, triglycerides), comprehensive metabolic panel (including creatinine for eGFR calculation), urine albumin-to-creatinine ratio, and TSH as your core new patient diabetes workup 1, 2.
Essential Laboratory Tests
Glycemic Assessment
- HbA1c: This is your primary glycemic control marker, reflecting average glucose over the past 2-3 months. Order this immediately to establish baseline control and guide treatment decisions 1, 3. If not checked in the previous 3 months, this is mandatory 4.
Cardiovascular Risk Assessment
- Fasting lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides): Critical for cardiovascular risk stratification in this 65-year-old patient, as approximately one-third of adults with type 2 diabetes have cardiovascular disease 5. Fasting is not strictly required for screening, but provides more accurate triglyceride values 6.
Kidney Function and Diabetic Nephropathy Screening
Comprehensive metabolic panel including:
- Serum creatinine (to calculate eGFR)
- Electrolytes
- Liver function tests
Urine albumin-to-creatinine ratio (uACR): Essential for detecting diabetic kidney disease. In type 2 diabetes, test at diagnosis since disease onset timing is uncertain 2. This should be done annually thereafter. Normal is <30 mg/g; moderately increased albuminuria is 30-299 mg/g; severely increased is ≥300 mg/g 2.
Thyroid Function
- TSH: Screen for thyroid dysfunction, which is more common in patients with diabetes, particularly in older women 7.
Additional Considerations
Glucose Monitoring
While not a "lab panel" item, establish a baseline fasting plasma glucose if the patient isn't already diagnosed, though HbA1c ≥6.5% confirms diabetes 1, 8. Point-of-care glucose monitoring frequency should be determined based on treatment regimen (insulin users need more frequent monitoring) 3.
Anemia Assessment
Consider adding a complete blood count (CBC) to evaluate for anemia, which can affect HbA1c interpretation and is common in older adults with chronic kidney disease 1, 9.
Important Caveats
HbA1c limitations: In patients with hemoglobinopathies, recent blood loss, transfusion, erythropoietin therapy, or significant anemia, HbA1c may not accurately reflect glycemic control. In these cases, rely on plasma glucose measurements and consider glycated albumin as an alternative 4, 9.
Timing: Blood for fasting glucose and lipids should be drawn after an overnight fast of at least 8 hours 1. However, non-fasting lipid panels are acceptable for initial screening 6.
Sample handling: Use tubes with citrate buffer for glucose samples to prevent glycolysis; sodium fluoride alone is insufficient 1.
Clinical Integration
After obtaining these baseline labs, you'll be positioned to:
- Assess current glycemic control and set individualized HbA1c targets (typically <7% for most adults, but <8% may be appropriate for this 65-year-old depending on comorbidities and life expectancy) 10
- Determine cardiovascular risk and need for statin therapy
- Stage chronic kidney disease using both eGFR and albuminuria categories 2
- Identify need for SGLT2 inhibitors or GLP-1 receptor agonists based on cardiovascular or kidney disease presence 5, 11, 12
This panel provides the foundation for comprehensive diabetes management while identifying complications that directly impact treatment selection and prognosis.